EXHIBIT 10.17 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. LICENSE AGREEMENT This Licensing Agreement (the "Agreement") is made effective the 1st day of March, 2002 (the...License Agreement • February 27th, 2004 • Alnylam Pharmaceuticals Inc • District of Columbia
EXHIBIT 10.5Registration Rights Agreement • February 27th, 2004 • Alnylam Pharmaceuticals Inc • Massachusetts
EXHIBIT 10.11 LOAN AND SECURITY AGREEMENT THIS LOAN AND SECURITY AGREEMENT (THIS "AGREEMENT") dated as of December 18, 2002, between SILICON VALLEY BANK, a California chartered bank, with its principal place of business at 3003 Tasman Drive, Santa...Loan and Security Agreement • February 27th, 2004 • Alnylam Pharmaceuticals Inc • Delaware
LEASEAlnylam Pharmaceuticals Inc • February 27th, 2004 • Massachusetts
EXHIBIT 10.19 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. CO-EXCLUSIVE LICENSE AGREEMENT between Garching Innovation GmbH, Hofgartenstrasse 8, 80539 Munchen, Germany,...License Agreement • February 27th, 2004 • Alnylam Pharmaceuticals Inc
Exhibit 10.13 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION...Alnylam Pharmaceuticals Inc • February 27th, 2004 • Massachusetts
EXHIBIT 10.23 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. SPONSORED RESEARCH AGREEMENT Effective as of 1 OCTOBER 2003, MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH,...Research Agreement • February 27th, 2004 • Alnylam Pharmaceuticals Inc • Mayo
ALNYLAM PHARMACEUTICALS, INC LICENCE AGREEMENTLicence Agreement • February 27th, 2004 • Alnylam Pharmaceuticals Inc • London
EXHIBIT 10.18 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. LICENSE AGREEMENT This License Agreement (this "Agreement"), is effective December 30, 2003 (the "Effective...License Agreement • February 27th, 2004 • Alnylam Pharmaceuticals Inc • New York
EXECUTION INVESTOR RIGHTS AGREEMENT THIS INVESTOR RIGHTS AGREEMENT (the "AGREEMENT") is entered into as of September 8, 2003 by and between Alnylam Holding Co., a Delaware corporation (the "CORPORATION"), and Merck & Co., Inc., a New Jersey...Investor Rights Agreement • February 27th, 2004 • Alnylam Pharmaceuticals Inc • Delaware
BY AND AMONGResearch Collaboration and License Agreement • February 27th, 2004 • Alnylam Pharmaceuticals Inc • New York
AGREEMENTAlnylam Pharmaceuticals Inc • February 27th, 2004 • California
EXHIBIT 10.12 UNCONDITIONAL GUARANTY For and in consideration of certain loans by SILICON VALLEY BANK, a California-chartered bank, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production...Alnylam Pharmaceuticals Inc • February 27th, 2004
